Regeneron, Sanofi's Dupixent Approved in Japan as Bullous Pemphigoid Treatment-March 2024-www.financetom.com

Regeneron, Sanofi's Dupixent Approved in Japan as Bullous Pemphigoid Treatment

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Regeneron, Sanofi's Dupixent Approved in Japan as Bullous Pemphigoid Treatment

Mar 24, 2026 12:37 AM

03:13 AM EDT, 03/24/2026 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) and Sanofi ( SNY ) said Tuesday the Ministry of Health, Labor and Welfare in Japan approved Dupixent, or dupilumab, as treatment for moderate-to-severe bullous pemphigoid, a rare skin disease.

The approval was based on data from a phase 2/3 trial that showed over four times more patients that received Dupixent experienced sustained disease remission through week 36, compared with placebo, the companies said in separate statements.

Previous page： This bank will cut bonus if employees don't come back to work Next page： Pakistan's national carrier resorts to flight cancellation owing to non-payment of dues

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

This bank will cut bonus if employees don't come back to work

Nov 22, 2023

ANZ managers have informed their respective teams about the new policy this week in generic emails, reaffirming the bank's expectation that staff devote at least half their working hours in the office each month, afr.com reported.

Pakistan's national carrier resorts to flight cancellation owing to non-payment of dues

Oct 23, 2023

The airline, which was once considered the pride of Pakistan and was the first international airline to be given access to fly to Beijing, is said to be suffering millions in losses on a daily basis.

Mahindra, Volvo among corporations pushing for fossil fuel exit at COP28

Oct 23, 2023

Companies are increasingly committing to their own timelines for reducing their emissions, but many acknowledge that their ability to slow planet-warming CO2 emissions is contingent on faster action from governments.

IMF warns Europe against prematurely declaring victory over inflation

Nov 8, 2023

The Washington-based IMF said that cost of underestimating inflation’s persistence could be painfully high and result in another painful round of rate hikes that could rob the economy of a large chunk of growth.